Budget impact of switching from an immediate-release to a prolonged-release formulation of tacrolimus in renal transplant recipients in the UK based on differences in adherence

References

• European Medicines AgencyAdvagraf European public assessment report annex I: summary of product characteristics Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000712/WC500022234.pdfAccessed June 4, 2013
   Google Scholar
• US Food and Drug AdministrationDrug approval package: Prograf (tacrolimus) injection2003 Available from: http://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/050708_prograf_toc.cfmAccessed June 4, 2013
   Google Scholar
• StaatzCETettSEClinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantationClin Pharmacokinet2004431062365315244495
   PubMed Web of Science ®Google Scholar
• DewMADiMartiniAFDe Vito DabbsARates and risk factors for nonadherence to the medical regimen after adult solid organ transplantationTransplantation200783785887317460556
   PubMed Web of Science ®Google Scholar
• DharancySGiralMTetazRFatrasMDubelLPageauxGPAdherence with immunosuppressive treatment after transplantation: results from the French trial PREDICTClin Transplant2012263E293E29922686953
   PubMed Web of Science ®Google Scholar
• WengFLIsraniAKJoffeMMRace and electronically measured adherence to immunosuppressive medications after deceased donor renal transplantationJ Am Soc Nephrol20051661839184815800121
   PubMed Web of Science ®Google Scholar
• National Health Service Business Services AuthorityPrescription cost analysis (PCA) data2013 Available from: http://www.nhsbsa.nhs.uk/PrescriptionServices/3494.aspxAccessed July 31, 2013
   Google Scholar
• European Medicines AgencyEuropean public assessment report: Advagraf – summary for the public2008 Available from: http://www.emea.europa.eu/docs/en_GB/document_library/EPAR_-_Summary_for_the_public/human/000712/WC500022235.pdfAccessed June 4, 2013
   Google Scholar
• SainiSDSchoenfeldPKaulbackKDubinskyMCEffect of medication dosing frequency on adherence in chronic diseasesAm J Manag Care2009156e22e3319514806
   PubMed Web of Science ®Google Scholar
• ClaxtonAJCramerJPierceCA systematic review of the associations between dose regimens and medication complianceClin Ther20012381296131011558866
   PubMed Web of Science ®Google Scholar
• KuypersDRPeetersPCSennesaelJJImproved adherence to tacrolimus once-daily formulation in renal recipients: a randomized controlled trial using electronic monitoringTransplantation201395233334023263559
   PubMed Web of Science ®Google Scholar
• DobbelsFRupparTDe GeestSDecorteAVan Damme-LombaertsRFineRNAdherence to the immunosuppressive regimen in pediatric kidney transplant recipients: a systematic reviewPediatr Transplant201014560361320214741
   PubMed Web of Science ®Google Scholar
• PinskyBWTakemotoSKLentineKLBurroughsTESchnitzlerMASalvalaggioPRTransplant outcomes and economic costs associated with patient noncompliance to immunosuppressionAm J Transplant20099112597260619843035
   PubMed Web of Science ®Google Scholar
• SpiveyCAChisholm-BurnsMADamadzadehBBillheimerDDetermining the effect of immunosuppressant adherence on graft failure risk among renal transplant recipientsClin Transplant20142819610424329814
   PubMed Web of Science ®Google Scholar
• ButlerJARoderickPMulleeMMasonJCPevelerRCFrequency and impact of nonadherence to immunosuppressants after renal transplantation: a systematic reviewTransplantation200477576977615021846
   PubMed Web of Science ®Google Scholar
• NHS Blood and TransplantTransplant activity in the UKActivity report 2011–12 Available from: http://www.organdonation.nhs.uk/statistics/transplant_activity_report/archive_activity_reports/pdf/ukt/activity_report_2011_12.pdfAccessed March 3, 2014
   Google Scholar
• McEwanPDixonSBaboolalKConwayPCurrieCJEvaluation of the cost effectiveness of sirolimus versus tacrolimus for immunosuppression following renal transplantation in the UKPharmacoeconomics2006241677916445304
   PubMed Web of Science ®Google Scholar
• KrämerBKCharpentierBBäckmanLTacrolimus once daily (Advagraf) versus twice daily (Prograf) in de novo renal transplantation: a randomized phase III studyAm J Transplant201010122632264320840480
   PubMed Web of Science ®Google Scholar
• ZhangJYuKFWhat’s the relative risk? A method of correcting the odds ratio in cohort studies of common outcomesJAMA199828019169016919832001
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care ExcellenceCG125: peritoneal dialysis – NICE guideline2012 Available from: http://guidance.nice.org.uk/CG125/NICEGuidance/pdf/EnglishAccessed June 4, 2013
   Google Scholar
• Renal AssociationHaemodialysis Available from: http://www.renal.org/clinical/guidelinessection/haemodialysis.aspxAccessed June 4, 2013
   Google Scholar
• Joint Formulary CommitteeBritish National Formulary onlineLondonBMJ Group and Pharmaceutical Press §8.2.2 Corticosteroids and other immunosuppressants: Tacrolimus (Advagraf)32013 Available from: http://www.medicinescomplete.com/mc/bnf/current/PHP5647-advagraf.htm. (Registration required)Accessed August 20, 2013
   Google Scholar
• Joint Formulary CommitteeBritish National Formulary onlineLondonBMJ Group and Pharmaceutical Press §8.2.2 Corticosteroids and other immunosuppressants: Tacrolimus (Prograf)32013 Available from: http://www.medicinescomplete.com/mc/bnf/current/PHP5643-prograf.htm. (Registration required)Accessed August 20, 2013
   Google Scholar
• Joint Formulary CommitteeBritish National Formulary onlineLondonBMJ Group and Pharmaceutical Press §8.2.2 Corticosteroids and other immunosuppressants: Tacrolimus (Adoport)32013 Available from: http://www.medicinescomplete.com/mc/bnf/current/PHP5643-prograf.htm. (Registration required)Accessed August 20, 2013
   Google Scholar
• Joint Formulary CommitteeBritish National Formulary onlineLondonBMJ Group and Pharmaceutical Press §8.2.1 Antiproliferative immunosuppressants: Mycophenolate mofetil32013 Available from: http://www.medicinescomplete.com/mc/bnf/current/PHP5609-mycophenolate-mofetil-non-proprietary.htm. (Registration required)Accessed August 20, 2013
   Google Scholar
• Joint Formulary CommitteeBritish National Formulary onlineLondonBMJ Group and Pharmaceutical Press §6.3.2 Glucocorticoid therapy: Betamethasone32013 Available from: http://www.medicinescom-plete.com/mc/bnf/current/PHP18872-betamethasone-non-proprietary.htm. (Registration required)Accessed August 20, 2013
   Google Scholar
• Joint Formulary CommitteeBritish National Formulary onlineLondonBMJ Group and Pharmaceutical Press §6.3.2 Glucocorticoid therapy: Methylprednisolone32013 Available from: http://www.medicinescomplete.com/mc/bnf/current/PHP4373-solu-medrone.htm. (Registration required)Accessed August 20, 2013
   Google Scholar
• Joint Formulary CommitteeBritish National Formulary onlineLondonBMJ Group and Pharmaceutical Press §8.2.2 Corticosteroids and other immunosuppressants: Antithymocyte immunoglobulin (rabbit)32013 Available from: http://www.medicinescomplete.com/mc/bnf/current/PHP5620-antithymocyte-immunoglobulin-rabbit.htm. (Registration required)Accessed August 20, 2013
   Google Scholar
• National Health ServiceNational Tariff 2012–13 Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/216214/dh_133578.xlsAccessed August 20, 2013
   Google Scholar
• MauskopfJASullivanSDAnnemansLPrinciples of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices – budget impact analysisValue Health200710533634717888098
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Clinical ExcellenceGuide to the methods of technology appraisal2008 Available from: http://www.nice.org.uk/media/B52/A7/TAMethodsGuideUpdatedJune2008.pdfAccessed June 4, 2013
   Google Scholar
• BeaudetAPalmerJLTimlinLCost-utility of exenatide once weekly compared with insulin glargine in patients with type 2 diabetes in the UKJ Med Econ201114335736621563878
   PubMedGoogle Scholar
• SellarésJde FreitasDGMengelMUnderstanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherenceAm J Transplant201212238839922081892
   PubMed Web of Science ®Google Scholar
• WiebeCGibsonIWBlydt-HansenTDEvolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplantAm J Transplant20121251157116722429309
   PubMed Web of Science ®Google Scholar
• SabbatiniMGarofaloGBorrelliSEfficacy of a reduced pill burden on therapeutic adherence to calcineurin inhibitors in renal transplant recipients: an observational studyPatient Prefer Adherence20148738124470756
   PubMed Web of Science ®Google Scholar
• GrivaKDavenportAHarrisonMNewmanSPNon-adherence to immunosuppressive medications in kidney transplantation: intent vs forgetfulness and clinical markers of medication intakeAnn Behav Med2012441859322454221
   PubMed Web of Science ®Google Scholar
• VoAAPengAToyodaMUse of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantationTransplantation20108991095110220110854
   PubMed Web of Science ®Google Scholar
• National Health ServiceThird National Immunoglobulin Database ReportLondonNHS2012
   Google Scholar
• Joint Formulary CommitteeBritish National Formulary onlineLondonBMJ Group and Pharmaceutical Press MabThera. Available from: http://www.medicinescomplete.com/mc/bnf/current/PHP5664-mabthera.htm. (Registration required)Accessed September 20, 2013
   Google Scholar
• GallifordJLawrenceCChanKEculizumab reverses resistant acute Antibody Mediated Rejection and prevents allograft lossPoster presented at: 14th Annual Congress of the British Transplantation SocietyMarch 9–11, 2011Bournemouth, UK
   Google Scholar
• Joint Formulary CommitteeBritish National Formulary onlineLondonBMJ Group and Pharmaceutical Press Soliris. Available from: http://www.medicinescomplete.com/mc/bnf/current/PHP5923-soliris.htm. (Regsitration required)Accessed September 18, 2013
   Google Scholar
• PuttarajappaCShapiroRTanHPAntibody-mediated rejection in kidney transplantation: a reviewJ Transplant2012201219372422577514
   PubMedGoogle Scholar
• GuiradoLCantarellCFrancoAEfficacy and safety of conversion from twice-daily to once-daily tacrolimus in a large cohort of stable kidney transplant recipientsAm J Transplant20111191965197121668633
   PubMed Web of Science ®Google Scholar